Skip to main content

Regional Management posts record Q4 revenue and dividend

Tipranks - Thu Feb 5, 4:18PM CST

Claim 50% Off TipRanks Premium

An announcement from Regional Management ( (RM) ) is now available.

On February 4, 2026, Regional Management reported fourth-quarter 2025 net income of $12.9 million and record revenue of $169.7 million, fueled by 13.1% portfolio growth, a surge in auto-secured lending, and tight cost controls that delivered an all-time-low 12.4% operating expense ratio; the company also repurchased nearly 197,000 shares during the quarter and maintained ample liquidity with $511 million of unused revolver capacity. The board declared a $0.30 per-share quarterly dividend payable March 12, 2026 to shareholders of record February 19, reflecting confidence in the balance sheet after year-end net finance receivables reached $2.1 billion against $1.7 billion of debt with 84% fixed-rate funding.

The most recent analyst rating on (RM) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Regional Management stock, see the RM Stock Forecast page.

Spark’s Take on RM Stock

According to Spark, TipRanks’ AI Analyst, RM is a Neutral.

Regional Management’s overall stock score reflects steady financial performance and strong earnings call results. However, technical indicators suggest a bearish trend, and high leverage remains a concern. The stock’s valuation and recent corporate events provide positive aspects, contributing to a balanced outlook.

To see Spark’s full report on RM stock, click here.

More about Regional Management

Regional Management Corp., traded on NYSE as RM, is a diversified consumer finance company providing secured, fixed-rate installment loans to borrowers with limited access to traditional credit, operating online and through branches in 19 U.S. states under the Regional Finance brand.

Average Trading Volume: 53,546

Technical Sentiment Signal: Strong Buy

Current Market Cap: $374M

See more insights into RM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.